Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

BREAKING NEWS: First-in-the-World #Ivermectin, #Mebendazole and #Fenbendazole Protocol in Cancer has been peer-reviewed and published on Sep.19, 2024! (4 min 52 seconds) InfoWars did a media piece on this breakthrough in Cancer Treatment.

11 Kommentare

Profilbild von Andrea M. G. G. Stramezzi
Andrea M. G. G. Stramezzivor 1 Jahr

Questa la storia di Joe Tippen, primo paziente con cancro terminale a essere guarito nel 2017, con gli antiparassitari. È ancora Cancer Free. Io iniziai a conoscere e a prescrivere Ivermectina (uso umano), già nel 2020. Con il Dr Makis, ci scambiammo le rispettive esperienze al Congresso di Washington e poi a quello di Tokyo, proprio mentre usciva la pubblicazione, peer review, col suo protocollo, menzionata nel video. Quasi ogni giorno, con un folto gruppo di Medici, ci scambiamo le esperienze e tutti noi, spesso rimaniamo sorpresi dall’efficacia in alcuni pazienti, e sulle tante e diverse patologie, che si ampiano sempre più, su cui dimostra efficacia. Ringrazio ancora una volta, il caro collega Sathoshi Ǒmura, Premio Nobel per la Medicina, per avere scoperto l’Ivermectina oltre 40 anni fa, salvando mlioni di vite umane. La stima che ha espresso nei miei confronti, scrivendomi una e.mail, ancora mi onora.

Profilbild von Mesothelioma Claims Center
Mesothelioma Claims Centervor 2 Jahren

An estimated $30 Billion has been set aside in asbestos trust funds for victims of mesothelioma and other asbestos-related cancers. Submit the simple form below or call 866-269-3435 to file a claim now.

Profilbild von Andrea M. G. G. Stramezzi
Andrea M. G. G. Stramezzivor 1 Jahr

Thank you, Mr Tippen, for your testimony. I’m a Physician in Italy, and I have been suggesting, and still do, those medicine in patients with cancer for a lot of time, with unbelievable results.

Profilbild von WilliamO
WilliamOvor 1 Jahr

👇👇👇👇👇👇👇👇

Profilbild von Brooks Byce
Brooks Bycevor 1 Jahr

@Adams29Lib Ivermectin can cure so many things and it is demonized by big pharma because it is a few cents per dose and cancer drugs and vaccines are the most profitable thing the big pharmaceutical companies have. They don’t want to cure anything. They want you on as many meds possible

Profilbild von The Michelle Moore Show
The Michelle Moore Showvor 1 Jahr

Just had Dr Makis on The Michelle Moore Show two weeks ago. During the show, we shared your story, Joe. Here’s the link;

Profilbild von Paul
Paulvor 1 Jahr

I CURED MY DOG WITH FUCK N HUGE TUMOR S I GAVE HER FENBENZEDOLE, CURED BRO MY QUESTION HOW LONG HAVE THESE FUCK N SNAKES THESE VIPERS KNOWN DOG DEWORMER CURES CANCER ? HOW FUCK N LONG

Profilbild von charles sterling
charles sterlingvor 1 Jahr

Conclusion The hybrid orthomolecular protocol represents a novel, integrative approach to cancer treatment, focusing on mitochondrial function and CSCs. While it has garnered attention and anecdotal support, its efficacy and safety require further clinical validation. As of June 2025, it remains a promising but unproven alternative, with ongoing discussions in scientific and public forums.

Profilbild von whodeyS8
whodeyS8vor 1 Jahr

Maybe tag the person you are referencing. @MakisMD

Profilbild von Krishnamurthy Alappan
Krishnamurthy Alappanvor 1 Jahr

Time to replace the term, organic, with, the concept of, Natural.🤔

Profilbild von 𝔓𝔲𝔟𝔩𝔦𝔲𝔰 🪶
𝔓𝔲𝔟𝔩𝔦𝔲𝔰 🪶vor 1 Jahr

God Bless 🙏👏🙏

Ähnliche Videos

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Joe Tippens

46,807 Aufrufe • vor 2 Monaten

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."

Sense Receptor

228,635 Aufrufe • vor 9 Monaten

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

160,046 Aufrufe • vor 1 Jahr

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

RXMEDS.STORE

16,612 Aufrufe • vor 3 Monaten